Literature DB >> 11168759

"Apocrine" poroma: review of the literature and case report.

H Kamiya1, Z Oyama, Y Kitajima.   

Abstract

BACKGROUND: "Apocrine" poroma has recently been proposed as a new term to designate a distinctive benign skin neoplasm with differentiation toward the folliculosebaceous-apocrine unit. CASE REPORT: In support of alternative differentiation, a case of apocrine poroma is reported in a 73-year-old man. A nodule on the right upper abdomen, which was thought clinically to be seborrheic keratosis or basal cell epithelioma, was excised. HISTOLOGY: Histologically, this neoplasm heterogeniously consisted of poroma-like, sebaceous and follicular epithelial components. Since these components share the common embryologic origin of the folliculosebaceous-apocrine unit, this histologic pattern indicates apocrine differentiation of the tumor.
CONCLUSION: This is an additional case to support the term "apocrine" poroma as a diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11168759     DOI: 10.1034/j.1600-0560.2001.280207.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Pigmented eccrine poroma: report of an atypical case with the use of dermoscopy.

Authors:  Fabiana Carvalho de Almeida; Silvana Maria de Morais Cavalcanti; Angela Cristina Rapela Medeiros; Márcia Almeida Galvão Teixeira
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

Review 2.  [Apocrine poroma. A relatively little known skin tumor with multilineage differentiation].

Authors:  K Flux; F Eckert
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 3.  Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.

Authors:  Nidal A Obaidat; Khaled O Alsaad; Danny Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

4.  Eccrine Poroma Arising within Nevus Sebaceous.

Authors:  Jong-Kil Seo; Min Kyung Shin; Ki-Heon Jeong; Mu-Hyoung Lee
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.